Alector amends IPO

Immuno-neurology company Alector Inc. (South San Francisco, Calif.) amended its IPO on NASDAQ and now plans to sell 9.3 million shares at $18-$20. At the midpoint, the company would raise $175.8 million and be valued at $1.3 billion. The offering is underwritten by Morgan Stanley, BofA Merrill Lynch, Cowen and Barclays...